Haim Paran1, Evgeny Edelstein, Baruch Klein, Mordechai Gutman. Show Affiliations » 1. Department of Surgery, Meir Medical Center, Kfar Saba, Israel. paranh@clalit.org.il
Abstract
Entities: Chemical Disease Species
Mesh： See more » Adenocarcinoma/drug therapyAdultAngiogenesis Inhibitors/administration & dosageAngiogenesis Inhibitors/adverse effectsAntibodies, Monoclonal/administration & dosageAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal, HumanizedAntimetabolites, Antineoplastic/administration & dosageAntimetabolites, Antineoplastic/adverse effectsAntineoplastic Agents, Phytogenic/administration & dosageAntineoplastic Agents, Phytogenic/adverse effectsAntineoplastic Combined Chemotherapy ProtocolsBevacizumabCamptothecin/administration & dosageCamptothecin/adverse effectsCamptothecin/analogs & derivativesColitis, Ischemic/chemically inducedColonoscopyFluorouracil/administration & dosageFluorouracil/adverse effectsHumansIrinotecanLeucovorinMaleRectal Neoplasms/drug therapy
Substances： See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntimetabolites, AntineoplasticAntineoplastic Agents, PhytogenicBevacizumabIrinotecanLeucovorinFluorouracilCamptothecin
Year: 2007 PMID： 17642404
Source DB: PubMed Journal: Isr Med Assoc J Impact factor: 0.892